surfaceoncology – Our chief executive officer, Robert Ross, M.D., offered perspective on what lies ahead for biotech in the latest issue of Life Science Leader. He and fellow leaders in the space provided insight into what they are looking towards for the future of this ever-evolving industry.
See what he and other biotech CEOs had to say here: https://bit.ly/3EdCNSQ